Jane Street’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $78.1M | Sell |
217,581
-87,551
| -29% | -$26.8M | 0.01% | 1100 |
|
|
2026
Q1 | $76.5M | Buy |
305,132
+85,386
| +39% | +$21.2M | 0.01% | 786 |
|
|
2025
Q4 | $60.5M | Buy |
219,746
+183,501
| +506% | +$50.2M | 0.01% | 833 |
|
|
2025
Q3 | $9.51M | Buy |
36,245
+612
| +2% | +$149K | ﹤0.01% | 2494 |
|
|
2025
Q2 | $7.8M | Buy |
+35,633
| New | +$7.62M | ﹤0.01% | 2454 |
|
|
2025
Q1 | – | Sell |
-21,266
| Closed | -$5.86M | – | 10775 |
|
|
2024
Q4 | $6.97M | Sell |
21,266
-43,941
| -67% | -$13.8M | ﹤0.01% | 2264 |
|
|
2024
Q3 | $19.6M | Sell |
65,207
-5,325
| -8% | -$1.63M | ﹤0.01% | 1256 |
|
|
2024
Q2 | $23.2M | Buy |
70,532
+63,996
| +979% | +$22.6M | 0.01% | 1197 |
|
|
2024
Q1 | $2.59M | Sell |
6,536
-60,644
| -90% | -$22.4M | ﹤0.01% | 3662 |
|
|
2023
Q4 | $23.7M | Buy |
67,180
+41,274
| +159% | +$14.6M | 0.01% | 1143 |
|
|
2023
Q3 | $9.72M | Buy |
25,906
+11,093
| +75% | +$4.29M | ﹤0.01% | 1811 |
|
|
2023
Q2 | $5.67M | Sell |
14,813
-15,772
| -52% | -$5.63M | ﹤0.01% | 2566 |
|
|
2023
Q1 | $10.6M | Buy |
30,585
+17,814
| +139% | +$5.21M | ﹤0.01% | 1584 |
|
|
2022
Q4 | $3.01M | Sell |
12,771
-28,383
| -69% | -$6.73M | ﹤0.01% | 3220 |
|
|
2022
Q3 | $10.1M | Buy |
41,154
+21,000
| +104% | +$6.4M | ﹤0.01% | 1684 |
|
|
2022
Q2 | $6.09M | Sell |
20,154
-9,178
| -31% | -$2.99M | ﹤0.01% | 2376 |
|
|
2022
Q1 | $12M | Buy |
29,332
+15,218
| +108% | +$5.96M | ﹤0.01% | 1754 |
|
|
2021
Q4 | $6.62M | Sell |
14,114
-9,360
| -40% | -$4.03M | ﹤0.01% | 2430 |
|
|
2021
Q3 | $9.96M | Sell |
23,474
-2,088
| -8% | -$880K | ﹤0.01% | 1812 |
|
|
2021
Q2 | $9.18M | Sell |
25,562
-8,189
| -24% | -$2.71M | ﹤0.01% | 1824 |
|
|
2021
Q1 | $9.51M | Buy |
33,751
+27,970
| +484% | +$8M | ﹤0.01% | 1595 |
|
|
2020
Q4 | $1.64M | Sell |
5,781
-1,937
| -25% | -$544K | ﹤0.01% | 3857 |
|
|
2020
Q3 | $2.12M | Buy |
+7,718
| New | +$2.04M | ﹤0.01% | 2941 |
|
|
2020
Q2 | – | Sell |
-14,241
| Closed | -$2.8M | – | 7648 |
|
|
2020
Q1 | $2.17M | Buy |
+14,241
| New | +$2.19M | ﹤0.01% | 1940 |
|
|
2019
Q4 | – | Sell |
-10,736
| Closed | -$1.52M | – | 5859 |
|
|
2019
Q3 | $1.52M | Buy |
+10,736
| New | +$1.48M | ﹤0.01% | 2106 |
|
|
2018
Q4 | – | Sell |
-4,215
| Closed | -$520K | – | 5817 |
|
|
2018
Q3 | $520K | Buy |
+4,215
| New | +$473K | ﹤0.01% | 3579 |
|
|
2018
Q2 | – | Sell |
-10,345
| Closed | -$913K | – | 5712 |
|
|
2018
Q1 | $913K | Buy |
10,345
+4,038
| +64% | +$378K | ﹤0.01% | 2763 |
|
|
2017
Q4 | $622K | Buy |
6,307
+907
| +17% | +$88.9K | ﹤0.01% | 2923 |
|
|
2017
Q3 | $520K | Buy |
+5,400
| New | +$489K | ﹤0.01% | 3046 |
|
|
2016
Q4 | – | Sell |
-25,310
| Closed | -$1.89M | – | 4705 |
|
|
2016
Q3 | $1.89M | Buy |
25,310
+12,679
| +100% | +$1.01M | 0.01% | 1262 |
|
|
2016
Q2 | $958K | Buy |
+12,631
| New | +$919K | ﹤0.01% | 2023 |
|
|
2015
Q4 | – | Sell |
-24,224
| Closed | -$1.31M | – | 4542 |
|
|
2015
Q3 | $1.31M | Buy |
+24,224
| New | +$1.41M | 0.01% | 1372 |
|
|
2014
Q1 | – | Sell |
-4,883
| Closed | -$240K | – | 3116 |
|
|
2013
Q4 | $240K | Sell |
4,883
-811
| -14% | -$38K | ﹤0.01% | 1857 |
|
|
2013
Q3 | $234K | Buy |
+5,694
| New | +$217K | ﹤0.01% | 2289 |
|
Other funds holding WST
GIM
Jane Street's WST Position: Q2 2026 in Review
Jane Street reduced its West Pharmaceutical (WST) stake by 29% in Q2 2026, selling an estimated $26.8M and leaving 217,581 shares worth $78.1M. The position accounts for 0.01% of the portfolio, ranked #1100.
Jane Street first reported a position in WST in Q3 2013 and has held it in 34 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- Jane Street held 217,581 shares of West Pharmaceutical worth $78.1M as of Q2 2026.
- Jane Street sold 87,551 West Pharmaceutical shares in Q2 2026, an estimated $26.8M.
- West Pharmaceutical made up 0.01% of Jane Street's portfolio in Q2 2026, its #1100 holding.
- Jane Street first reported a position in West Pharmaceutical in Q3 2013 and has held it in 34 quarters since.
- 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.